Skip to main content
SpringerLink
Log in

Response to Senn Paper (Drug Information Journal, 2001;35: 1479–1494)

  • Correspodence
  • Letter to the Editor
  • Published:
Drug information journal : DIJ / Drug Information Association Aims and scope Submit manuscript

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

References

  1. Senn S. Individual therapy: New dawn or false dawn? Drug Inf J. 2001: 35: 1479–1494.

    Article  Google Scholar 

  2. Guyatt GH, Juniper EF, Walter SD, Griffith LE, Goldstein RS. Interpreting treatment effects in randomised trials. Br Med J. 1998;316:690–693.

    Article  CAS  Google Scholar 

  3. Shumaker RC, Metzler CM. The phenytoin trial is a case study of “individual bioequivalence.” Drug Inf J. 1998;32: 1063–1072.

    Article  Google Scholar 

  4. Walter SD. Number needed to treat (NNT): estimation of a measure of clinical benefit. Stat Med. 2001;20:3947–3962.

    Article  CAS  Google Scholar 

  5. Guyatt G, Juniper EF, Goldstein RS. Applying results of randomised trials to patients (letter). Br Med J. 1998;317:537.

    Article  Google Scholar 

  6. Waller SD, Irwig L. Estimating the number needed to treat (NNT) index when the data are subject to error. Stat Med. 2001;20:893–906.

    Article  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Department of Clinical Epidemiology & Biostatistics Hamilton, McMaster University, HSC-2C16, Hamilton, Ontario, Canada, L8N 3Z5

    Stephen D. Waller PhD & Gordon Guyatt MD, MSc, FRCP (C)

Authors
  1. Stephen D. Waller PhD
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Gordon Guyatt MD, MSc, FRCP (C)
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Stephen D. Waller PhD.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Waller, S.D., Guyatt, G. Response to Senn Paper (Drug Information Journal, 2001;35: 1479–1494). Ther Innov Regul Sci 37, 3–5 (2003). https://doi.org/10.1177/009286150303700102

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1177/009286150303700102

Search

Navigation